Inicio>>Adekalant tartrate

Adekalant tartrate (Synonyms: Adekalant; H 345/52; H345/52; H-345/52; H 34552; H34552; H-34552;)

Catalog No.GB62226

Adekalant, also known as H 345/52.

Products are for research use only. Not for human use. We do not sell to patients.

Adekalant tartrate Chemical Structure

Cas No.: 263892-42-8

Tamaño Precio Disponibilidad Cantidad
1mg
120,00 $
Disponible
5mg
450,00 $
Disponible
10mg
750,00 $
Disponible
25mg
1.650,00 $
Disponible
50mg
2.950,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
Adekalant, also known as H 345/52. is a new antiarrhythmic compound with low proarrhythmic activity. Adekalant concentration-dependently blocked HERG-carried currents with an IC50 of 230 nM. Adekalant preferentially bound to the open channel with unusually rapid kinetics and was trapped by channel closure. Voltage-independent behavior of Adekalant was observed during both square-pulse and action potential clamp protocols. It is proposed that block of I(Kr) is the principal mechanism by which Adekalant delays repolarization in human myocardium. Adekalant blocks I(Kr) with high potency and I(Ca) with somewhat lower potency and was found to delay ventricular repolarization without substantially increasing temporal or spatial dispersion and without inducing early after-depolarizations or TdP.

Reseñas

Review for Adekalant tartrate

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Adekalant tartrate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.